Send Message
Home News

company news about Prostate Cancer: A Growing Men's Health Concern Worldwide

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
Prostate Cancer: A Growing Men's Health Concern Worldwide
Latest company news about Prostate Cancer: A Growing Men's Health Concern Worldwide

The Lancet Prostate Cancer Commission has issued a warning, highlighting the projection that global cases of prostate cancer will double by 2040, reaching 2.9 million, with a corresponding 85% increase in deaths, total nearly 700,000.


Prostate cancer is a significant health concern that affects men worldwide. It is a malignant tumor that develops in the prostate gland, a small gland located below the bladder, surrounding the urethra. Prostate cancer is the most common cancer among men, except non-melanoma skin cancer, and it places a substantial burden on healthcare systems globally.


The incidence of prostate cancer varies across different regions, it is influenced by factors such as age, ethnicity and lifestyle. According to the latest data available, prostate cancer accounted for approximately 7.3% of all new cancer cases worldwide in 2020. The highest incidence rates were observed in regions like North America, Europe, and Australia, while lower rates were seen in parts of Asia and Africa.


Age is a significant risk factor for prostate cancer, with the majority of cases occurring in men over the age of 50. Incidence and mortality rates steadily increase with age, and the disease is relatively uncommon among younger men. Genetic factors and a family history of prostate cancer also contribute to the risk of developing the disease.


Prostate cancer screening primarily involves the prostate-specific antigen (PSA) test, which measures PSA levels in the blood. Elevated levels indicate the presence of prostate cancer, further diagnostic testing, such as a prostate biopsy, is necessary for confirmation. The decision of screening should consider an individual's risk factors, preferences, and discussions with their healthcare provider, weighing the potential benefits and risks of early detection and treatment.


Public health initiatives aim to raise awareness about prostate cancer, promote healthy lifestyles, and encourage regular screening among individuals at risk. Early detection and timely intervention play crucial roles in improving outcomes and reducing mortality associated with prostate cancer.

Pub Time : 2024-04-15 09:00:56 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)